bf/NASDAQ:XERS_icon.jpeg

NASDAQ:XERS

Xeris Biopharma Holdings, Inc.

  • Stock

USD

Last Close

7.71

06/11 22:33

Market Cap

319.49M

Beta: -

Volume Today

1.82M

Avg: 1.25M

PE Ratio

−4.97

PFCF: −4.75

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-13.21M
-
-26.55M
101.03%
-60.08M
126.26%
-91.14M
51.70%
-122.72M
34.66%
-94.66M
22.87%
-94.66M
0%
-62.26M
34.23%
depreciation and amortization
116K
-
177K
52.59%
320K
80.79%
1.47M
358.44%
1.88M
28.08%
12.67M
574.19%
12.67M
0%
13.16M
3.88%
deferred income tax
-414K
-
536K
229.47%
1.11M
108.02%
-1.42M
227.71%
-1.42M
0%
-1.25M
12.29%
stock based compensation
540K
-
499K
7.59%
1.73M
246.29%
8.27M
378.76%
11.38M
37.57%
12.16M
6.84%
12.16M
0%
10.72M
11.88%
change in working capital
-3.58M
-
1.12M
131.29%
1.61M
43.35%
-2.80M
274.11%
11.85M
523.66%
-35.15M
396.52%
-35.15M
0%
-6.29M
82.09%
accounts receivables
204K
-
-1.10M
638.24%
-1.67M
52.09%
-2.18M
30.66%
-6.24M
185.84%
-13.37M
114.43%
-13.37M
0%
-8.37M
37.44%
inventory
-846K
-
1.70M
300.71%
4.04M
138.04%
-5.14M
227.24%
-7.42M
44.23%
-7.46M
0.63%
-7.46M
0%
-14.80M
98.31%
accounts payables
-2.91M
-
661K
122.72%
-1.11M
267.93%
-2.49M
123.96%
5.53M
322.33%
-4.32M
178.13%
-4.32M
0%
6.96M
261.16%
other working capital
-32K
-
-140K
337.50%
345K
346.43%
7.01M
1,932.75%
19.98M
184.93%
-9.99M
150.01%
-9.99M
0%
9.92M
199.25%
other non cash items
49K
-
94K
91.84%
560K
495.74%
3.10M
454.29%
961K
69.04%
3.52M
265.76%
3.52M
0%
-2.29M
165.04%
net cash provided by operating activities
-16.09M
-
-24.66M
53.31%
-56.28M
128.19%
-80.56M
43.14%
-95.53M
18.59%
-102.89M
7.70%
-102.89M
0%
-48.21M
53.15%
investments in property plant and equipment
-35K
-
-700K
1,900%
-1.51M
115.71%
-377K
75.03%
-1.08M
187.80%
-524K
51.71%
-524K
0%
-2.26M
331.87%
acquisitions net
377K
-
38.47M
10,103.98%
38.47M
0%
purchases of investments
-68.85M
-
-101.77M
47.82%
-43.02M
57.73%
-43.02M
0%
-43.74M
-
sales maturities of investments
2.10M
-
74.75M
3,459.29%
103.60M
38.60%
34.98M
66.23%
34.98M
0%
40M
14.33%
other investing activites
-377K
-
4.55M
-
net cash used for investing activites
-35K
-
-700K
1,900%
-68.26M
9,651.57%
-27.41M
59.85%
97.96M
457.47%
34.46M
64.82%
34.46M
0%
-6.00M
117.42%
debt repayment
-32K
-
-25.09M
-
-25.09M
0%
-43.50M
73.37%
-43.50M
0%
common stock issued
98.33M
-
65.89M
32.99%
27M
59.02%
30M
11.11%
30M
0%
581K
98.06%
common stock repurchased
-63K
-
-534K
747.62%
-468K
12.36%
-468K
0%
-1.01M
115.60%
dividends paid
-95.64M
-
-25.09M
73.77%
-147.05M
-
other financing activites
3.94M
-
35.14M
792.76%
29.89M
14.95%
180.97M
505.53%
50.96M
71.84%
141.44M
177.55%
288.49M
103.97%
-1
100.00%
net cash used provided by financing activities
3.90M
-
35.14M
800.08%
128.21M
264.87%
126.06M
1.67%
27.25M
78.39%
127.47M
367.84%
127.47M
0%
-428K
100.34%
effect of forex changes on cash
-22K
-
-3K
86.36%
-3K
0%
123K
-
net change in cash
-12.22M
-
9.78M
180.01%
3.67M
62.45%
18.08M
392.48%
29.67M
64.13%
59.04M
98.98%
59.04M
0%
-54.52M
192.33%
cash at beginning of period
44.49M
-
32.27M
27.46%
42.05M
30.30%
19.52M
53.58%
37.60M
92.62%
67.27M
78.92%
67.27M
0%
121.97M
81.31%
cash at end of period
32.27M
-
42.05M
30.30%
45.72M
8.73%
37.60M
17.76%
67.27M
78.92%
126.31M
87.77%
126.31M
0%
67.45M
46.60%
operating cash flow
-16.09M
-
-24.66M
53.31%
-56.28M
128.19%
-80.56M
43.14%
-95.53M
18.59%
-102.89M
7.70%
-102.89M
0%
-48.21M
53.15%
capital expenditure
-35K
-
-700K
1,900%
-1.51M
115.71%
-377K
75.03%
-1.08M
187.80%
-524K
51.71%
-524K
0%
-2.26M
331.87%
free cash flow
-16.12M
-
-25.36M
57.32%
-57.79M
127.85%
-80.94M
40.05%
-96.62M
19.38%
-103.42M
7.03%
-103.42M
0%
-50.47M
51.20%

All numbers in USD (except ratios and percentages)